India to Canada: Ezetimibe Export Trade Route

The India to Canada Ezetimibe corridor is one of India's established pharmaceutical export routes, with 184 shipments documented worth a combined $4.0M USD. The route is dominated by EMCURE PHARMACEUTICALS LIMITED, which alone accounts for roughly 49% of all export value, reflecting the consolidated nature of India's ezetimibe manufacturing sector.

Across 12 active suppliers, the average shipment value stands at $21.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with ezetimibe's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 20.0%, placing it at rank #6 among India's top ezetimibe export destinations globally.

On the import side, key buyers of Indian ezetimibe in Canada include MARCAN PHARMACEUTICALS INC.,, MARCAN PHARMACEUTICALS INC, MARCAN PHARMACEUTICALS INC. and 20 others. MARCAN PHARMACEUTICALS INC., is the single largest importer with 48 shipments valued at $1.0M USD.

India's ezetimibe exports to Canada are driven primarily by a handful of large-scale manufacturers. EMCURE PHARMACEUTICALS LIMITED with 94 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 12 active exporters signals a competitive but concentrated market — buyers in Canada benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — EMCURE PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED, EMCURE PHARMACEUTICALS LTD — together account for 71% of total trade value on this route. The average shipment value of $21.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pharma drugs and medi ezetimibe 10mg 100 and pharma drugs and medi ezetimibe 10mg 3x1 , suggesting that buyers in Canada tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MARCAN PHARMACEUTICALS INC., is the largest importer with 48 shipments worth $1.0M USD — representing 26% of all ezetimibe imports from India on this route. A total of 23 buyers are active on this corridor.